Document is current

Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer

Crossref DOI link: https://doi.org/10.1186/s13046-020-01805-6

Published Online: 2021-01-05

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy